🔎 Trials Near Me

Home › Colon Cancer › New Jersey

Colon Cancer clinical trials in New Jersey

15 studies for Colon Cancer are looking for participants at sites in New Jersey.

Cities in New Jersey

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0060), Hackensack
  • Atlantic Health System ( Site 0093), Summit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06997497

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 12, Morristown
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07085091

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  • Hackensack University Medical Center, Hackensack
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07629960

Evaluating Novel Therapies in ctDNA Positive GI Cancers

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05482516

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Astera Cancer Care, East Brunswick
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

  • Morristown Medical Center, Morristown
Recruiting
Ages 45 to 70 · All sexes · Updated Sep 2, 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

  • AtlantiCare Health Park-Cape May Court House, Cape May Court House
  • Jefferson Cherry Hill Hospital, Cherry Hill
  • AtlantiCare Surgery Center, Egg Harbor
  • and 16 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05174169

Shield Post-Approval Study Protocol

  • Gastroenterology Associates of New Jersey, LLC, Clifton
  • Gastroenterology Associates of New Jersey, LLC, Montclair
  • Gastroenterology Associates of New Jersey, LLC, Ridgewood
  • and 1 more
RecruitingObservational studyHealthy volunteers welcome
Ages 45 to 81 · All sexes · Updated Aug 7, 2026 · NCT06880055

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • Xencor Investigative Site, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT05433142

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

  • Trinitas Hospital and Comprehensive Cancer Center, Elizabeth
  • RWJBarnabas Health Jersey City Medical Center, Jersey City
  • RWJBarnabas Health - Monmouth Medical Center Southern Campus, Lakewood
  • and 6 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 18, 2026 · NCT05806931

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

  • START, Astera, East Brunswick
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT07145255

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Jan 23, 2026 · NCT00582621

Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery

  • Robert Wood Johnson University Hospital, Hamilton, Hamilton
  • Monmouth Medical Center, Lakewood
  • RWJBarnabas Health - Monmouth Medical Center Southern Campus, Lakewood
  • and 7 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 6, 2026 · NCT05296681

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, New Brunswick
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.